{"cik":2096997,"taxonomy":"us-gaap","tag":"LiabilitiesCurrent","label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","entityName":"Kailera Therapeutics, Inc.","units":{"USD":[{"end":"2025-12-31","val":46405000,"accn":"0001193125-26-239417","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-26"},{"end":"2025-12-31","val":46405000,"accn":"0001193125-26-346958","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12","frame":"CY2025Q4I"},{"end":"2026-03-31","val":54836000,"accn":"0001193125-26-239417","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-26","frame":"CY2026Q1I"},{"end":"2026-06-30","val":83651000,"accn":"0001193125-26-346958","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12","frame":"CY2026Q2I"}]}}